Published in J Immunol on June 01, 1999
Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun (2002) 1.45
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene. J Virol (2006) 1.35
Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector. J Virol (2000) 1.22
Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes. J Virol (2004) 1.06
Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein. PLoS One (2012) 1.01
The influence of delivery vectors on HIV vaccine efficacy. Front Microbiol (2014) 0.92
Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS. J Virol (2010) 0.91
Reflections on the early development of poxvirus vectors. Vaccine (2013) 0.88
The infectious bursal disease virus RNA-binding VP3 polypeptide inhibits PKR-mediated apoptosis. PLoS One (2012) 0.85
Enhancing poxvirus vectors vaccine immunogenicity. Hum Vaccin Immunother (2014) 0.85
Host-range restriction of vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 protein. PLoS One (2011) 0.82
Modulation of HIV-1 immunity by adjuvants. Curr Opin HIV AIDS (2014) 0.78
T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizations. PLoS One (2011) 0.78
Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro. J Virol (2006) 0.77
Transfected Plasmodium knowlesi produces bioactive host gamma interferon: a new perspective for modulating immune responses to malaria parasites. Infect Immun (2003) 0.75
Lineage specific antigenic differences in porcine torovirus hemagglutinin-esterase (PToV-HE) protein. Vet Res (2013) 0.75
Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors. Viruses (2016) 0.75
Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ (1987) 4.65
Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13
Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature (1989) 4.08
The dsRNA protein kinase PKR: virus and cell control. Biochimie (2007) 3.67
Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int J Parasitol (2001) 3.51
Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science (1985) 3.24
Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med (1983) 3.07
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol (1985) 3.06
Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods (1995) 2.82
The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology (1994) 2.78
Monoclonal antibodies to circumsporozoite proteins identify the species of malaria parasite in infected mosquitoes. Nature (1982) 2.76
CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol (1991) 2.67
Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res (1994) 2.65
Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis (2000) 2.63
A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol (1987) 2.53
DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. Science (1984) 2.47
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A (1993) 2.44
Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology (1990) 2.27
Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. J Immunol (1985) 2.09
Deubiquitinases in cancer: new functions and therapeutic options. Oncogene (2011) 2.08
Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology (1984) 2.04
Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol (1997) 2.00
Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages. J Exp Med (2001) 1.99
Vaccinia virus 15-kilodalton (A14L) protein is essential for assembly and attachment of viral crescents to virosomes. J Virol (1998) 1.91
Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J Virol (1995) 1.89
Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J Virol (1987) 1.87
Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol (1992) 1.86
The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J Virol (1993) 1.86
Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J Immunol (1997) 1.80
Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci U S A (1988) 1.78
Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology (1998) 1.73
Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc Natl Acad Sci U S A (1994) 1.68
Early virus protein synthesis in vaccinia virus-infected cells. J Gen Virol (1973) 1.63
Antibodies to the protective antigen of Plasmodium berghei sporozoites prevent entry into cultured cells. J Immunol (1982) 1.63
Direct mapping of nuclear shell effects in the heaviest elements. Science (2012) 1.63
Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus. Nature (1972) 1.63
Identification of malaria-infected mosquitoes by a two-site enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1984) 1.60
Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment. J Virol (1997) 1.60
A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus. Virology (1987) 1.59
The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med (1992) 1.56
Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol (1999) 1.54
Structural and functional characterization of a cell surface binding protein of vaccinia virus. J Biol Chem (1990) 1.54
CD4+ cytolytic T cell clone confers protection against murine malaria. J Exp Med (1990) 1.51
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol (1995) 1.47
Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J Exp Med (1990) 1.46
Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA. Proc Natl Acad Sci U S A (1985) 1.41
Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol Cell Biol (1996) 1.40
Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol (1996) 1.38
A vaccinia virus core protein, p39, is membrane associated. J Virol (1996) 1.37
Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology (1997) 1.35
Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol (1993) 1.33
Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene. Proc Natl Acad Sci U S A (1986) 1.31
Isolation and characterization of attenuated mutants of vaccinia virus. Virology (1987) 1.30
The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology (1993) 1.29
The synthesis of encephalomyocarditis virus polypeptides in infected L-cells and cell-free systems. Eur J Biochem (1974) 1.28
Prevalence and levels of antibodies to the circumsporozoite protein of Plasmodium falciparum in an endemic area and their relationship to resistance against malaria infection. Trans R Soc Trop Med Hyg (1988) 1.27
The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology (1997) 1.26
Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J Virol (1998) 1.25
Development of antimalaria immunity in mice lacking IFN-gamma receptor. J Immunol (1995) 1.25
Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence. J Virol (1987) 1.25
Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites. J Immunol Methods (1986) 1.25
Studies on the mechanism of entry of vaccinia virus in animal cells. Arch Virol (1987) 1.25
Structure of vaccinia DNA: analysis of the viral genome by restriction endonucleases. Virology (1978) 1.23
Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Biochem Biophys Res Commun (1997) 1.22
Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector. J Virol (2000) 1.22
Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei. Eur J Immunol (1988) 1.22
The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals. J Virol (1991) 1.22
Defective vaccinia virus particles in interferon-treated infected cells. Virology (1984) 1.21
Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J Virol (1996) 1.20
Interaction of benzodiazepines with mouse macrophages. Eur J Pharmacol (1984) 1.19
First field trial of an immunoradiometric assay for the detection of malaria sporozoites in mosquitoes. Am J Trop Med Hyg (1984) 1.19
Structural and functional properties of the 14-kDa envelope protein of vaccinia virus synthesized in Escherichia coli. J Biol Chem (1990) 1.18
Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus. J Virol (1999) 1.17
Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Biochem Biophys (1993) 1.16
The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology (1993) 1.16
Isolation and characterization of protective cytolytic T cells in a rodent malaria model system. Immunol Lett (1990) 1.16
Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proc Natl Acad Sci U S A (1998) 1.16
The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene (2000) 1.15
ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses. J Immunol Methods (2001) 1.15
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol (1999) 1.15
Replication of vaccinia DNA in mouse L cells. I. In vivo DNA synthesis. Virology (1977) 1.14
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc Natl Acad Sci U S A (1989) 1.14
Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology (1997) 1.14
Inhibition of idiotype--anti-idiotype interaction for detection of a parasite antigen: a new immunoassay. Science (1982) 1.13
Vaccinia virus transcription: hybridization of mRNA to restriction fragments of vaccinia DNA. Virology (1978) 1.12
Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus. J Virol (1987) 1.12